[{"id":"38a358aa-4637-4d62-88fe-5f1f4ce41f8d","acronym":"","url":"https://clinicaltrials.gov/study/NCT03692637","created_at":"2021-01-18T18:05:54.027Z","updated_at":"2024-07-02T16:37:03.340Z","phase":"Phase 1","brief_title":"Study of Anti-Mesothelin Car NK Cells in Epithelial Ovarian Cancer","source_id_and_acronym":"NCT03692637","lead_sponsor":"Allife Medical Science and Technology Co., Ltd.","biomarkers":" PD-L1 • PD-1 • MSLN","pipe":" | ","alterations":" MSLN expression • MSLN positive","tags":["PD-L1 • PD-1 • MSLN"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSLN expression • MSLN positive"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MSLN CAR-T • anti-Mesothelin CAR NK Cells"],"overall_status":"Unknown status","enrollment":" Enrollment 30","initiation":"Initiation: 03/01/2019","start_date":" 03/01/2019","primary_txt":" Primary completion: 11/01/2020","primary_completion_date":" 11/01/2020","study_txt":" Completion: 11/01/2021","study_completion_date":" 11/01/2021","last_update_posted":"2019-01-31"}]